Gemella sanguinis Collins et al. (ATCC® 700632)

Strain Designations: CDC 2045-94 [CCUG 37820, SS-1508]  /  Type Strain: yes  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Strain Designations CDC 2045-94 [CCUG 37820, SS-1508]
Blood - human
Augusta Georgia, United States
isolation date: 1993
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain yes (type strain)
Medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor RR Facklam
Special Collection NCRR Contract
Chain of Custody
ATCC <<--RR Facklam<<--University Hospital, Augusta, GA
Blood - human
Augusta Georgia, United States
isolation date: 1993
Year of Origin 1993

Validation list no. 68. Int. J. Syst. Bacteriol. 49: 1-3, 1999.

Collins MD, et al. Description of Gemella sanguinis sp. nov., isolated from human clinical specimens. J. Clin. Microbiol. 36: 3090-3093, 1998. PubMed: 9738079

type strain

blood of a 41-year-old man, Augusta

type strain

Cross References

Nucleotide (GenBank) : Y13364 16S rRNA sequence

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation